The Walter Reed Army Institute of Research was recognized May 24 by Intercell for its contributions in the research, development and clinical testing of the newly licensed Japanese Encephalitis vaccine. WRAIR initiated the vaccine project and contributed to numerous aspects of the development of the vaccine up to licensure. As a result of this public-private partnership, military personnel, dependents, and civilians will be protected against the serious and growing risk of disease caused by JE when travelling to many countries of the world.